journal article·2023-01Open access

Surface Decoration of Peptide Nanoparticles Enables Efficient Therapy toward Osteoporosis and Diabetes

Tianhe Huang, Guan Wang, Mohammad‐Ali Shahbazi, Yuancheng Bai, Jingrui Zhang, Guobing Feng, Elham Asadian, Fatemeh Ghorbani‐Bidkorpeh, Zhiyuang Yang, Yuanai Li, Qingqing Huo, Yingxin Liu, Dongfei Liu

Advanced Functional Materials· Volume 33· Issue 2

Abstract

Abstract A versatile surface decoration strategy to efficiently encapsulate water‐soluble peptides is developed. By assembling peptide molecules into nanoparticles, diverse physiochemical properties of these compacted molecules are equalized to the surface properties of nanoparticles. Primarily driven by the generic electrostatic attractions, the surface of as‐prepared peptide nanoparticles is decorated with charged amino acids‐grafted poly(lactic‐co‐glycolic acid). This adsorbed polymer layer versatilely blocks the phase transfer of peptide nanoparticles by increasing their affinity to the dispersed phase solvent molecules. Attributed to the ultrahigh encapsulation efficiencies (> 96%), the peptide mass fraction inside the obtained microcomposites is higher than 48%. The plasma calcium level has been efficiently reduced for ≈3 weeks with only one single injection of salmon calcitonin‐encapsulated microcomposite in osteoporotic rats. Similarly, one single injection of exenatide‐encapsulated microcomposites efficiently controls the glycemic level in type 2 diabetic rats for up to 3 weeks. Overall, the developed versatile surface decoration strategy efficiently encapsulates peptides and improves their pharmacokinetic features, regardless of the molecular structure of peptide cargos.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Supramolecular Self-Assembly in Materials · Polymer Surface Interaction Studies · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Natural Medicines NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients Department of Pharmaceutical Science China Pharmaceutical University Nanjing 210009 China

Department of Biomedical Engineering University Medical Center Groningen University of Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands

W.J. Kolff Institute for Biomedical Engineering and Materials Science University of Groningen/ University Medical Center Groningen Antonius Deusinglaan 1 9713 AV Groningen The Netherlands

Department of Pharmaceutics School of Pharmacy Zanjan University of Medical Sciences Zanjan 45139–56184 Iran

Department of Tissue Engineering and Applied Cell Sciences School of Advanced Technologies in Medicine Shahid Beheshti University of Medical Sciences Tehran 19689‐17313 Iran

Medical Nanotechnology and Tissue Engineering Research Center Shahid Beheshti University of Medical Sciences Tehran 19689‐17313 Iran

Department of Pharmaceutics and Pharmaceutical Nanotechnology School of Pharmacy Shahid Beheshti University of Medical Science Tehran 19968–35113 Iran

Funding

National Natural Science Foundation of China · Natural Science Foundation of Jiangsu Province · China Pharmaceutical University

References (44)

Show source-provided references
1. 10.1038/s41586-021-03772-010.1038/s41586-021-03772-0 ↗
2. 10.1038/s41586-019-1036-310.1038/s41586-019-1036-3 ↗
3. 10.1038/s41586-020-2892-610.1038/s41586-020-2892-6 ↗
4. 10.1039/B801739P10.1039/B801739P ↗
5. 10.1126/sciadv.160051910.1126/sciadv.1600519 ↗
6. 10.1126/science.aaf744710.1126/science.aaf7447 ↗
7. 10.1038/nmat478110.1038/nmat4781 ↗
8. 10.1126/sciadv.abi815710.1126/sciadv.abi8157 ↗
9. 10.1038/s41563-021-01057-510.1038/s41563-021-01057-5 ↗
10. 10.1038/nature1830610.1038/nature18306 ↗
11. 10.1126/science.aac475010.1126/science.aac4750 ↗
12. 10.1126/sciadv.aay952610.1126/sciadv.aay9526 ↗
13. 10.1038/nmat377610.1038/nmat3776 ↗
14. 10.1126/science.109583310.1126/science.1095833 ↗
15. Lu X. · Sci. Transl. Med. · 2020 · 12 · 1695
16. 10.1021/nl104117p10.1021/nl104117p ↗
17. 10.1038/s41578-019-0150-z10.1038/s41578-019-0150-z ↗
18. 10.1038/s41578-021-00358-010.1038/s41578-021-00358-0 ↗
19. 10.1038/nrd163210.1038/nrd1632 ↗
20. 10.1021/jacs.7b1277610.1021/jacs.7b12776 ↗
21. 10.1038/s41467-019-09354-z10.1038/s41467-019-09354-z ↗
22. 10.1021/ar300064710.1021/ar3000647 ↗
23. 10.1016/j.addr.2019.01.00210.1016/j.addr.2019.01.002 ↗
24. 10.1038/nature0132810.1038/nature01328 ↗
25. 10.1038/nature0394610.1038/nature03946 ↗
26. 10.1002/adma.20140540810.1002/adma.201405408 ↗
27. 10.1002/adfm.20160450810.1002/adfm.201604508 ↗
28. 10.1021/acs.nanolett.6b0325110.1021/acs.nanolett.6b03251 ↗
29. 10.1016/j.biomaterials.2014.10.07910.1016/j.biomaterials.2014.10.079 ↗
30. 10.1002/smll.20130374010.1002/smll.201303740 ↗
31. 10.1063/1.46439710.1063/1.464397 ↗
32. 10.1016/S0140-6736(08)61206-410.1016/S0140-6736(08)61206-4 ↗
33. R.Müller H. V.Campenhout B. V.Damme G.Perre P.Rüegsegger Bone1998 23 59.10.1016/S8756-3282(98)00068-4 ↗
34. 10.1172/JCI99010.1172/JCI990 ↗
35. 10.1038/s41551-017-007810.1038/s41551-017-0078 ↗
36. 10.1080/10717544.2021.193875610.1080/10717544.2021.1938756 ↗
37. Huang T. · Asian J. Pharm · 2019 · 14 · 609
38. 10.1002/jcc.2133410.1002/jcc.21334 ↗
39. 10.1021/acs.molpharmaceut.8b0005610.1021/acs.molpharmaceut.8b00056 ↗
40. 10.1002/jcc.1012010.1002/jcc.10120 ↗
41. 10.1016/j.actbio.2009.04.01210.1016/j.actbio.2009.04.012 ↗
42. 10.1002/1097-4636(2001)58:3<291::AID-JBM1019>3.0.CO;2-N10.1002/1097-4636(2001)58:3<291::AID-JBM1019>3.0.CO;2-N ↗
43. 10.1016/j.cmpb.2010.01.00710.1016/j.cmpb.2010.01.007 ↗
44. 10.1007/s00394-013-0622-710.1007/s00394-013-0622-7 ↗